This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
University of Liverpool scientists have discovered how a protein linked to a severe form of childhood epilepsy is positioned within nerve cells, providing new insights into a rare genetic neurological disorder.
CDKL5 deficiency disorder (CDD) is a rare neurological condition that causes severe epilepsy beginning in early infancy, alongside significant developmental difficulties. It is caused by mutations in a gene called CDKL5, which produces a protein essential for normal brain development and function.
CDD is estimated to occur in approximately 1 in 40,000 to 60,000 live births worldwide. Although scientists have known about CDKL5 for a number of years, little is known about how this protein works inside nerve cells and why mutations cause such profound neurological problems.
New research led by professor of mechanistic cell biology Ben Goult now provides a framework for understanding how CDKL5 works and how mutations might disrupt brain development.
The paper, "Cyclin-dependent kinase-like 5 (CDKL5) binds talin and is anchored at the postsynaptic density by direct PDZ interactions," is published in Science Advances.
A crucial new finding is the identification of a previously unrecognized molecular docking mechanism that attaches CDKL5 to the structural framework of synapses. This discovery reveals how CDKL5 is positioned at synapses, something that has, until now, remained unclear despite years of research into this protein.
Importantly, the study shows that where CDKL5 is located within nerve cells is just as important as what it does.
Source link







